New coronavirus strain and its impact on vaccine strategy
With the new COVID19 virus strain (B1.1.7.) throwing the entire world into a frenzied state, it is important to understand its impact on healthcare and vaccine strategies.
With the new COVID19 virus strain (B1.1.7.) throwing the entire world into a frenzied state, it is important to understand its impact on healthcare and vaccine strategies.
With more than 180 vaccines are currently being developed against COVID19 virus, it important than ever to understand the approaches for developing vaccines and how they will be distributed across the world.
Predicting the course of COVID-19 is essential for best treatment outcome for the patients.
CRISPR-Cas9 is one of only a handful of technological marvels that have made a paradigm shifting and lasting impact on healthcare.
We are a world class research-intensive institute. We deliver clinical diagnostics, genetic counselling, teaching and R&D of the highest quality. Attracting and retaining high-calibre people is fundamental to our continued success.
More than 200 vaccines are currently being developed against COVID19 virus, across the globe. What is the structure of coronavirus and what strategies are used for developing vaccines is discussed in a live interview with Doordarshan Girnar.
**Taking aspirin regularly can prevent bowel cancer in high-risk patients even after ‘20 years’, data from randomised controlled trial shows.**
ERNDIM certification ensures highest quality of standardised procesudre for diagnosis, treatment and monitoring of inherited metabolic diseases are followed.
A detailed analysis on the impact of covid19 outbreak on India penned by the students of FRIGE.
Several research groups, hospitals, nations and the World Health Organisation (WHO) have been playing active role to sequence the RNA of the COVID19 virus. Its purpose and utility is discussed in a live interview with the Gujarat Samachar TV.
Diagnosing autism spectrum disorders (ASDs) is often challenging as mutation in several genes can lead to the disease. Systematic application of latest genomic technologies could improve diagnosis and reduce cost.
Diagnosis of lysosomal storage disorders (LSD) is often challenging due to overlapping clinical symptoms and costly chemicals. We are developing a sequencing based assay that can diagnose over 20 LSDs simultaneously.
Over our 25 years history, we have been fortunate to meet and receive praise from noted dignitories, scientists and the general public. Their words enthuse us to strive towards excellence in delivering diagnostics and research.
Genetics is currently going through a rapid expansion in its suite of techniques and technologies. Understanding these technologies and using them in research and diagnostic settings is key for their robust implementation in clinics.
Lysosomal Storage Disorders (LSDs) are a group of 70 diseases that are characterised by an impaired lysosome enzyme and occurs in 1 in 5000 births. Diagnosing these diseases is extremely challenging as it requires accurate clinical data collection and subsequent use of specific lysosomal enzyme substrates.
Colorectal cancer, also known as bowel cancer, is the sixth most common cancer in India. National health agencies of USA, UK, France and India. recommend all bowel cancers to be tested for a specific type of “DNA spelling mistakes” called microsatellite instability or MSI for short.